Spanish tennis player Rafael Nadal, who will play this week in the Rio Open, downplayed public concerns over risks linked to the Zika virus in the Brazilian city that will host the Olympics in August, saying "people are living completely normal lives."
"I'm not at all afraid," Nadal, 29, told a press conference.
"I go out at night, and I know there's a risk, but I'm just happy to be back here again.
"If I get sick well then that's just bad luck," insisted the 14-time Grand Slam winner. I can see for myself that people here are going about their business as if everything was okay, so things can't be that bad.
"I see people conducting their lives normally... I see people walking, people on the beach, people in restaurants, people having completely normal lives," the world's former top player Nadal told reporters at the Jockey Club, which is hosting the Rio Open.
World No 6 and Nadal’s fellow Spaniard, David Ferrer said he had been reassured by Brazil's efforts to wipe out the mosquitoes which carry the virus.
"We've been told that everything possible has been done so that there will be no mosquitoes, which is comforting," he said.
"We've been wearing long trousers at night but I'm not getting obsessed by the whole thing."
Nadal is one of the first major sports figures to compete in the city since Brazil became the focal point for the virus that has spread rapidly across the Americas. Health officials believe it is linked to microcephaly, a condition marked by abnormally small head size that can result in developmental problems.
Despite a recent surge in reports of infants born with these birth defects in Brazil's northeast that world health officials say is likely linked to the mosquito-born virus, Nadal, who has qualified for the men's singles tennis event at the Games, said the situation in Rio "was not likely to be so serious."
Several athletes and visitors planning to come to the Olympics have expressed concern about Zika, which has been reported in more than 30 countries, according to the World Health Organization.
There are currently no vaccines or treatment for the virus, though research institutes and pharmaceutical companies are working on several possibilities.
